age-related macular edema
Showing 1 - 25 of >10,000
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Beijing (Intravitreal injection of IBI302(dose 1),
Suspended
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- Intravitreal injection of IBI302(dose 1)
- +3 more
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jul 17, 2023
Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)
Not yet recruiting
- Diabetic Macular Edema (DME)
- Neovascular Age-Related Macular Degeneration (nAMD)
- aflibercept 8 mg PFS
- (no location specified)
Aug 3, 2023
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Austin (AIV007)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
-
Austin, TexasRetina Consultants of Austin
Jan 16, 2023
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Mesa, Phoenix (Faricimab PFS Configuration)
Completed
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- Faricimab PFS Configuration
-
Mesa, Arizona
- +2 more
Jan 2, 2023
Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME) Trial in United States (EYE103)
Recruiting
- Neovascular Age-related Macular Degeneration (NVAMD)
- Diabetic Macular Edema (DME)
-
Phoenix, Arizona
- +4 more
Jun 14, 2023
Anti-VEGF in Real-world
Recruiting
- Neovascular Age-related Macular Edema
- +5 more
- Ranibizumab
- +2 more
-
Beijing, Beijing, ChinaWen-Bin Wei
Feb 2, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in San Antonio (D-4517.2)
Recruiting
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
-
Los Angeles, California
- +11 more
Jan 11, 2023
Diabetic Retinopathy, Diabetic Macular Edema, Age-Related Macular Degeneration Trial in France (Eye Fundus Double Capture for
Not yet recruiting
- Diabetic Retinopathy
- +4 more
- Eye Fundus Double Capture for Eye Diseases Screening with OphtAI Medical Device
-
Brest, France
- +7 more
Feb 21, 2023
Learn More About How Well Aflibercept 8 mg Works in Treating
Not yet recruiting
- Visual Impairment
- +2 more
- Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)
-
Multiple Locations, Australia
- +5 more
Oct 4, 2023
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)
Recruiting
- Neovascular Age-related Macular Degeneration
- +2 more
- BD311
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Aug 22, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in United States (AR-13503 Implant 10.6 Dose,
Completed
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- AR-13503 Implant 10.6 Dose
- +3 more
-
Gilbert, Arizona
- +5 more
Jun 9, 2022
Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation, Proliferative Diabetic Retinopathy Trial in Perugia
Not yet recruiting
- Macular Degeneration, Age Related
- +4 more
- VISUPRIME
- Placebo
-
Perugia, PG, ItalyOspedale Santa Maria della Misericordia
Dec 22, 2022
Diabetic Macular Edema, Neovascular Age-related Macular Degeneration Trial in United States (UBX1325)
Completed
- Diabetic Macular Edema
- Neovascular Age-related Macular Degeneration
-
Beverly Hills, California
- +7 more
Mar 8, 2022
Gain Clinical Insights Into Roche Ophthalmology Products
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- Faricimab
- Port Delivery System with Ranibizumab
- (no location specified)
Jul 25, 2022
Intravitreal Injection, Ocular Rinse, Age-Related Macular Degeneration Trial in Oklahoma City (OSDI questionnaire, SPEEDII
Completed
- Intravitreal Injection
- +4 more
- OSDI questionnaire
- SPEEDII questionnaire
-
Oklahoma City, OklahomaDean McGee Eye Institute
Nov 7, 2022
Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis), Central Retinal Vein Occlusion With Macular Edema, Exudative
Completed
- Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis)
- +6 more
- Refresh Plus Preservative-free Lubricant Eye Drops
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics - Department of Ophthalmo
Apr 16, 2023
Diabetic Macular Edema, Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Banha (Anti-vascular endothelial
Recruiting
- Diabetic Macular Edema
- +4 more
- Anti-vascular endothelial growth factors (Anti-VEGFs)
-
Banhā, Benha, EgyptAhmed Abdelshafy Tabl
Aug 8, 2022
Neovascular Age-related Macular Degeneration, Age-related Macular Degeneration, Diabetic Retinopathy Trial in Durham (AngioVue
Terminated
- Neovascular Age-related Macular Degeneration
- +4 more
- AngioVue SD-OCT
-
Durham, North CarolinaDuke Eye Center
Mar 29, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Brisbane (D-4517.2)
Completed
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
-
Brisbane, Queensland, AustraliaNucleus Network (Brisbane)
Sep 19, 2022
Use of Aflibercept Injections Into Eye for Treatment of Eye
Recruiting
- Retinal Disease
- Aflibercept (BAY86-5321, Eylea)
-
Multiple Locations, MexicoMany locations
Aug 22, 2022
Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Springfield,
Active, not recruiting
- Age-Related Macular Degeneration
- +4 more
- bevacizumab
-
Springfield, Illinois
- +2 more
Dec 6, 2021
Wet Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in United States (KSI-301)
Terminated
- Wet Age-related Macular Degeneration
- +2 more
-
Phoenix, Arizona
- +10 more
Nov 1, 2022
Collateral Damage From COVID-19 Pandemic Observed in Patients
Completed
- Age Related Macular Degeneration
- +2 more
- Questionnaire
- Data collection up to 1 year
-
Ecully, France
- +3 more
Mar 2, 2022
Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in Vienna (MacInfo presentation, Placebo
Recruiting
- Age-related Macular Degeneration
- +2 more
- MacInfo presentation
- Placebo presentation
-
Vienna, AustriaVienna Institute for Research in Ocular Surgery (VIROS), Hanusch
Jan 24, 2022